Paloma Partners’s Alimera Sciences ALIM Stock Holding History

Paloma Partners’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,607	Closed	-$140K	–	2189
2016 Q2	$140K	Buy	+7,607	New	+$202K	﹤0.01%	2037

Other funds holding ALIM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Scale Management Foster City, California $359M AUM

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paloma Partners's ALIM Position: Q3 2016 in Review

Paloma Partners sold out of Alimera Sciences (ALIM) in Q3 2016, closing a stake of 7,607 shares — an estimated $140K sold.

Paloma Partners first reported a position in ALIM in Q2 2016 and held it in 1 quarter. The position peaked at $140K in Q2 2016. 54 funds tracked by Wall St. Rank hold ALIM as of Q3 2016.

Paloma Partners reported no remaining Alimera Sciences position as of Q3 2016 after selling out during the quarter.
Paloma Partners sold 7,607 Alimera Sciences shares in Q3 2016, an estimated $140K.
Paloma Partners first reported a position in Alimera Sciences in Q2 2016 and held it in 1 quarter.
Paloma Partners's Alimera Sciences position peaked at $140K in Q2 2016.
54 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.